Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2 messenger RNA.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 2915826)

Published in Arthritis Rheum on April 01, 2010

Authors

Puneet Seth1, Heather N Yeowell

Author Affiliations

1: Duke University Medical Center, Durham, North Carolina 27710, USA.

Articles cited by this

Using CLUSTAL for multiple sequence alignments. Methods Enzymol (1996) 20.99

Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet (2004) 5.47

Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol Cell Biol (2005) 5.03

Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev (2008) 4.24

Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res (2005) 4.06

A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J (2003) 3.44

Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev (1994) 3.20

Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A (2003) 2.87

Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing. Nucleic Acids Res (2001) 2.70

Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One (2008) 2.66

A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol (1997) 2.66

Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem (2003) 2.63

Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Mol Cell Biol (1998) 2.51

RNAi-mediated PTB depletion leads to enhanced exon definition. Mol Cell (2002) 2.34

Neuron-specific alternative splicing of nonmuscle myosin II heavy chain-B pre-mRNA requires a cis-acting intron sequence. J Biol Chem (1996) 2.24

The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic Acids Res (2005) 2.20

Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Mol Cell Biol (2006) 2.18

X-chromosome-counting mechanisms that determine nematode sex. Nature (1997) 1.72

Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood (2001) 1.66

An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol Cell Biol (1998) 1.64

A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol (2003) 1.63

Androgens regulate the mammalian homologues of invertebrate sex determination genes tra-2 and fox-1. Biochem Biophys Res Commun (2001) 1.32

Post-translational processing of procollagens. Ann N Y Acad Sci (1985) 1.30

Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta (2004) 1.25

Genetic and molecular analysis of fox-1, a numerator element involved in Caenorhabditis elegans primary sex determination. Genetics (1999) 1.21

Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol (2004) 1.16

Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res (2004) 1.13

The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Arch Dermatol Res (2006) 1.12

Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J Bone Miner Res (2004) 1.12

Cloning and characterization of a novel human lysyl hydroxylase isoform highly expressed in pancreas and muscle. J Biol Chem (1997) 1.11

Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum (2004) 1.08

Lysyl hydroxylase 2 is a specific telopeptide hydroxylase, while all three isoenzymes hydroxylate collagenous sequences. Matrix Biol (2007) 1.03

Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum (2005) 1.03

Of urchins and men: evolution of an alternative splicing unit in fibroblast growth factor receptor genes. RNA (2003) 1.03

Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol (2004) 1.02

Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene. Matrix Biol (1999) 0.98

Overhydroxylation of lysyl residues is the initial step for altered collagen cross-links and fibril architecture in fibrotic skin. J Invest Dermatol (1999) 0.92

Scleroderma--pathophysiology. Eur J Dermatol (2008) 0.91

Tissue-specific expression and regulation of the alternatively-spliced forms of lysyl hydroxylase 2 (LH2) in human kidney cells and skin fibroblasts. Matrix Biol (2004) 0.90

Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc. J Biol Chem (2008) 0.88

Scleroderma gene expression and pathway signatures. Curr Rheumatol Rep (2008) 0.82

TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2. J Invest Dermatol (2008) 0.81

Understanding systemic sclerosis through gene expression profiling. Curr Opin Rheumatol (2007) 0.78